287 related articles for article (PubMed ID: 25010505)
1. The prognostic role of troponin I elevation after elective percutaneous coronary intervention.
Auguadro C; Scalise F; Manfredi M; Casali V; Novelli E; Specchia G
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):149-55. PubMed ID: 25010505
[TBL] [Abstract][Full Text] [Related]
2. Troponin I elevation and all-cause mortality after elective percutaneous coronary interventions.
Ferreira RM; de Souza E Silva NA; Salis LHA; da Silva RRM; Maia PD; Horta LFB; Salles EF; Nunes HMP; de Oliveira JBM; Domingues YPS; de Sousa CCM
Cardiovasc Revasc Med; 2017 Jun; 18(4):255-260. PubMed ID: 28131744
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
[TBL] [Abstract][Full Text] [Related]
5. Final myocardial blush grade predicts troponin I elevation in unstable angina patients undergoing percutaneous intervention.
Prasan AM; Flood C; Pitney MR; Walsh W; Jepson NS
Heart Lung Circ; 2006 Oct; 15(5):291-6. PubMed ID: 16860603
[TBL] [Abstract][Full Text] [Related]
6. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
[TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value.
Okmen E; Cam N; Sanli A; Unal S; Tartan Z; Vural M
Angiology; 2006; 57(2):161-9. PubMed ID: 16518523
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
[TBL] [Abstract][Full Text] [Related]
9. Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).
Veselka J; Hájek P; Tomašov P; Tesař D; Brůhová H; Matějovič M; Branny M; Studenčan M; Zemánek D
Am J Cardiol; 2014 Feb; 113(3):446-51. PubMed ID: 24304551
[TBL] [Abstract][Full Text] [Related]
10. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of troponin I after elective percutaneous coronary interventions.
Drzewiecka-Gerber A; Drzewiecki J; Wita K; Krauze J; Jaklik A; Trusz-Gluza M; Mróz I
Kardiol Pol; 2004 Aug; 61(8):117-26; discussion 126. PubMed ID: 15457278
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
13. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
14. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction evaluated by peripheral arterial tonometry is related with peak TnI values in patients with ST elevation myocardial infarction treated with primary angioplasty.
Baptista SB; Faustino M; Simões J; Nédio M; Monteiro C; Lourenço E; Leal P; Farto eAbreu P; Gil V
Microvasc Res; 2016 May; 105():34-9. PubMed ID: 26721522
[TBL] [Abstract][Full Text] [Related]
16. The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion.
Di Serafino L; Borgia F; Maeremans J; Pyxaras SA; De Bruyne B; Wijns W; Heyndrickx G; Dens J; Di Mario C; Barbato E
Am J Cardiol; 2014 Oct; 114(8):1158-64. PubMed ID: 25152423
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
[TBL] [Abstract][Full Text] [Related]
19. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
20. Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction.
Piestrzeniewicz K; Luczak K; Goch JH
Neuro Endocrinol Lett; 2008 Aug; 29(4):581-8. PubMed ID: 18766137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
